Is ELV or GSK cheaper?

On trailing earnings, GSK is cheaper: ELV trades at a 16.81 P/E and GSK at 11.62.

Which has grown faster, ELV or GSK?

Over the past five years, ELV grew revenue faster — ELV at a 9.97% CAGR versus GSK at 0.63%.

Does ELV or GSK pay a bigger dividend?

ELV yields 1.74% and GSK yields 3.51% based on trailing dividends and the latest price.

Is ELV or GSK more profitable?

GSK runs the higher net margin — ELV at 2.62% versus GSK at 17.76%.

Which has been the better investment, ELV or GSK?

Over the past 10-year, ELV delivered the higher annualized total return — ELV at 13.63% versus GSK at 7.50%. Past performance doesn't predict future results.

Elevance Health Inc. (ELV) vs GSK plc (GSK)

GSK leads on 13 of 16 compared metrics.

A side-by-side comparison of Elevance Health Inc. and GSK plc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 27, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Total return — ELV vs GSK

growth of $100 · last 25y

ELV +1832.4%GSK -2.1%ELV compounded faster

Log scale — wide-divergence pair

ELV GSK

ELV vs GSK: by the numbers

•GSK is the larger company ($105.20B vs $85.82B market cap).
•GSK trades at the lower earnings multiple (11.62 vs 16.81 P/E).
•GSK converts more revenue to profit (17.76% vs 2.62% net margin).
•ELV grew revenue faster over the past five years (9.97% vs 0.63% CAGR).
•GSK pays the higher dividend yield (3.51% vs 1.74%).

Which is better, ELV or GSK?

Metric tally: ELV 3 · GSK 13

It depends on what you're optimizing for:

ValueGSK(lower P/E)

GrowthELV(faster 5Y revenue CAGR)

IncomeGSK(higher dividend yield)

QualityGSK(higher ROIC)

Metrics side by side

Valuation

Metric	ELV	GSK
P/E ratio	16.81	11.62●
Forward P/E	13.52	13.25
P/S ratio	0.43●	2.42
P/B ratio	1.98●	3.44
PEG ratio	2.52	0.02●
EV / EBITDA	12.26	8.62●
FCF yield	7.41%	7.87%●

Profitability

Metric	ELV	GSK
Gross margin	23.16%	72.67%●
Operating margin	3.81%	25.65%●
Net margin	2.62%	17.76%●
ROE	11.94%	25.19%●
ROIC	6.65%	16.61%●

Dividends

Metric	ELV	GSK
Dividend yield	1.74%	3.51%●
Payout ratio	27.32%	24.30%

Growth (annualized)

Metric	ELV	GSK
Revenue CAGR (5Y)	9.97%●	0.63%
EPS CAGR (5Y)	6.67%	14.05%●
FCF CAGR (5Y)	-7.76%	-0.35%●
Total return CAGR (5Y)	2.20%	10.18%●

Frequently asked

Which is better, ELV or GSK?: It depends on your goal. value: GSK (lower P/E); growth: ELV (faster 5Y revenue CAGR); income: GSK (higher dividend yield); quality: GSK (higher ROIC). Across all compared metrics, GSK leads 13 to 3.
Is ELV or GSK cheaper?: On trailing earnings, GSK is cheaper: ELV trades at a 16.81 P/E and GSK at 11.62.
Which has grown faster, ELV or GSK?: Over the past five years, ELV grew revenue faster — ELV at a 9.97% CAGR versus GSK at 0.63%.
Does ELV or GSK pay a bigger dividend?: ELV yields 1.74% and GSK yields 3.51% based on trailing dividends and the latest price.
Is ELV or GSK more profitable?: GSK runs the higher net margin — ELV at 2.62% versus GSK at 17.76%.
Which has been the better investment, ELV or GSK?: Over the past 10-year, ELV delivered the higher annualized total return — ELV at 13.63% versus GSK at 7.50%. Past performance doesn't predict future results.

Go deeper

Full ELV analysis Full GSK analysis Interactive comparison tool

Dig into the metrics

Elevance Health P/E ratio GSK P/E ratio Elevance Health dividend yield GSK dividend yield Elevance Health ROE GSK ROE Elevance Health operating margin GSK operating margin Elevance Health revenue growth GSK revenue growth Elevance Health free cash flow GSK free cash flow

Elevance Health & GSK appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest FCF Yield Stocks Best 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 27, 2026.